GAITHERSBURG, Md., March 10, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company" or "Cytomedix"), a leading developer of biologically active regenerative therapies for wound care and tissue repair, today announced that it has appointed Gary R. Otto to the newly-created position of Director of National Accounts effective March 21, 2011.
